Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 945112
                    [Title] => World Hypertension Day Urgent appeal: Quit smoking
                    [Summary] => 
Quit smoking now for your and your loved ones’ sake.

                    [DatePublished] => 2013-05-23 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 580425
                    [Title] => 'Heart failure is deadly'
                    [Summary] => 
Local experts warned against the deadly threat posed by heart failure and urged the general public to be vigilant in preventing the common condition and recognizing its symptoms.
                    [DatePublished] => 2010-06-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 464585
                    [Title] => Victims of stroke, heart attack getting younger - experts
                    [Summary] => 
MANILA,  Philippines – Time was when only middle-aged and older patients were known to be suffering from complications of atherosclerosis, or the narrowing of arteries in the body.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 457561
                    [Title] => JUPITER study ushers in new paradigm
                    [Summary] => 
Local heart experts agree with their foreign colleagues that findings of a new landmark study will change the way doctors treat apparently healthy and low-risk patients.
                    [DatePublished] => 2009-04-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 443172
                    [Title] => Stroke, heart attack victims getting younger
                    [Summary] => 
Time was when only middle-aged and older patients were known to be suffering from complications of atherosclerosis, or the narrowing of arteries in the body.
                    [DatePublished] => 2009-02-26 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 237722
                    [Title] => Results of landmark heart study bared
                    [Summary] => More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that researchers hope will change the medical landscape in the management of heart diseases.


Results of VALIANT (Valsartan in Acute Myocardial Infarction Trial) was presented to doctors from all over the country by Prof. Inder Anand, chief of the Cardiology Section of the Veterans Affair Medical Center in Minneapolis, USA. 


                    [DatePublished] => 2004-02-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 226915
                    [Title] => Experts debate first-line therapy for heart failure
                    [Summary] => Results of new clinical trials are reinforcing the role of the angiotensin receptor blockers (ARBs) in the treatment of patients with heart failure (HF). 


Previously, the angiotensin converting enzyme inhibitors (ACEi) were considered as first-line drug in HF patients. Now, heart experts are debating if ARBs can also be considered as another first-line drug to be given with ACEi or to replace it altogether in those who cannot tolerate ACEi due to side-effects, which can be as many as 35 percent of HF patients. 


                    [DatePublished] => 2003-11-06 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 225185
                    [Title] => Study shows hope for heart failure patients
                    [Summary] => Patients with heart failure still carry a high rate of death and re-hospitalization. There is still a big need to come up with new therapies which can significantly optimize treatment of patients suffering from heart failure. 


Angiotensin receptor blockers (ARB), a class of drugs popularly prescribed for high blood pressure, are filling in this need. 


                    [DatePublished] => 2003-10-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

DR. ROMEO DIVINAGRACIA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 945112
                    [Title] => World Hypertension Day Urgent appeal: Quit smoking
                    [Summary] => 
Quit smoking now for your and your loved ones’ sake.

                    [DatePublished] => 2013-05-23 00:00:00
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [1] => Array
                (
                    [ArticleID] => 580425
                    [Title] => 'Heart failure is deadly'
                    [Summary] => 
Local experts warned against the deadly threat posed by heart failure and urged the general public to be vigilant in preventing the common condition and recognizing its symptoms.
                    [DatePublished] => 2010-06-03 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [2] => Array
                (
                    [ArticleID] => 464585
                    [Title] => Victims of stroke, heart attack getting younger - experts
                    [Summary] => 
MANILA,  Philippines – Time was when only middle-aged and older patients were known to be suffering from complications of atherosclerosis, or the narrowing of arteries in the body.
                    [DatePublished] => 2009-05-07 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [3] => Array
                (
                    [ArticleID] => 457561
                    [Title] => JUPITER study ushers in new paradigm
                    [Summary] => 
Local heart experts agree with their foreign colleagues that findings of a new landmark study will change the way doctors treat apparently healthy and low-risk patients.
                    [DatePublished] => 2009-04-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [4] => Array
                (
                    [ArticleID] => 443172
                    [Title] => Stroke, heart attack victims getting younger
                    [Summary] => 
Time was when only middle-aged and older patients were known to be suffering from complications of atherosclerosis, or the narrowing of arteries in the body.
                    [DatePublished] => 2009-02-26 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [5] => Array
                (
                    [ArticleID] => 237722
                    [Title] => Results of landmark heart study bared
                    [Summary] => More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that researchers hope will change the medical landscape in the management of heart diseases.


Results of VALIANT (Valsartan in Acute Myocardial Infarction Trial) was presented to doctors from all over the country by Prof. Inder Anand, chief of the Cardiology Section of the Veterans Affair Medical Center in Minneapolis, USA. 


                    [DatePublished] => 2004-02-05 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [6] => Array
                (
                    [ArticleID] => 226915
                    [Title] => Experts debate first-line therapy for heart failure
                    [Summary] => Results of new clinical trials are reinforcing the role of the angiotensin receptor blockers (ARBs) in the treatment of patients with heart failure (HF). 


Previously, the angiotensin converting enzyme inhibitors (ACEi) were considered as first-line drug in HF patients. Now, heart experts are debating if ARBs can also be considered as another first-line drug to be given with ACEi or to replace it altogether in those who cannot tolerate ACEi due to side-effects, which can be as many as 35 percent of HF patients. 


                    [DatePublished] => 2003-11-06 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

            [7] => Array
                (
                    [ArticleID] => 225185
                    [Title] => Study shows hope for heart failure patients
                    [Summary] => Patients with heart failure still carry a high rate of death and re-hospitalization. There is still a big need to come up with new therapies which can significantly optimize treatment of patients suffering from heart failure. 


Angiotensin receptor blockers (ARB), a class of drugs popularly prescribed for high blood pressure, are filling in this need. 


                    [DatePublished] => 2003-10-23 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Science and Environment
                    [SectionUrl] => science-and-environment
                    [URL] => 
                )

        )

)

abtest

World Hypertension Day Urgent appeal: Quit smoking

May 23, 2013 - 12:00am

Quit smoking now for your and your loved ones’ sake.

Science and Environment

'Heart failure is deadly'

June 3, 2010 - 12:00am

Local experts warned against the deadly threat posed by heart failure and urged the general public to be vigilant in preventing the common condition and recognizing its symptoms.

Science and Environment

Victims of stroke, heart attack getting younger - experts

May 7, 2009 - 12:00am

MANILA, Philippines – Time was when only middle-aged and older patients were known to be suffering from complications of atherosclerosis, or the narrowing of arteries in the body.

Science and Environment

JUPITER study ushers in new paradigm

April 16, 2009 - 12:00am

Local heart experts agree with their foreign colleagues that findings of a new landmark study will change the way doctors treat apparently healthy and low-risk patients.

Science and Environment

Stroke, heart attack victims getting younger

February 26, 2009 - 12:00am

Time was when only middle-aged and older patients were known to be suffering from complications of atherosclerosis, or the narrowing of arteries in the body.

Science and Environment

Results of landmark heart study bared

February 5, 2004 - 12:00am

More than 2,000 heart specialists and other practicing physicians gathered at the Le Pavillion in Manila last Jan. 22 to listen to the presentation of the results and clinical implications of a landmark study that...

Science and Environment

Experts debate first-line therapy for heart failure

November 6, 2003 - 12:00am

Results of new clinical trials are reinforcing the role of the angiotensin receptor blockers (ARBs) in the treatment of patients with heart failure (HF). Previously, the angiotensin converting enzyme inhibitors...

Science and Environment

Study shows hope for heart failure patients

October 23, 2003 - 12:00am

Patients with heart failure still carry a high rate of death and re-hospitalization. There is still a big need to come up with new therapies which can significantly optimize treatment of patients suffering from heart...

Science and Environment